ADVERTISEMENT

Home|Journals|Articles by Year|Audio Abstracts
 

Case Report

. 2025; 2(2): 32-35


Cerebral Toxoplasmosis: Effectiveness of Clindamycin Monotherapy in a Patient with Sulfonamide Allergy

Margareth Hildaria, Gabriel Alden Setiawan.



Abstract
Download PDF Cited by 0 ArticlesPost

Cerebral toxoplasmosis is a severe condition often associated with HIV-positive patients. It can present as a neurological emergency, making early detection and prompt treatment crucial to preventing further neurological damage. We present a 34-year-old man, previously undiagnosed with HIV, who presented with worsening headaches, photophobia, dizziness, nausea, vomiting, and slurred speech. Neurological examination revealed left-sided central facial (VII) and hypoglossal (XII) nerve palsies. Laboratory tests confirmed HIV infection and elevated anti-toxoplasma antibodies. Imaging showed multiple ring-enhancing lesions, vasogenic edema, and a midline shift. The patient was treated with clindamycin, folic acid, citicoline, paracetamol, and dexamethasone. Symptoms improved within three days, with resolution of headaches and improvement in speech. Follow-up CT scans after 6 weeks showed reduced edema and lesion size. Cerebral toxoplasmosis as the initial manifestation of HIV is rare but critical finding. Early diagnosis and treatment are essential for improved outcomes, highlighting the need to consider cerebral toxoplasmosis as a potential early sign of HIV infection. This case demonstrates that clindamycin alone can be an effective treatment for cerebral toxoplasmosis, particularly in resource-poor settings or for patients with sulfonamide allergies.

Key words: cerebral toxoplasmosis, vasogenic edema, clindamycin, monotherapy, sulfonamide allergy







Bibliomed Article Statistics

28
17
8
16
16
11
17
17
1
R
E
A
D
S

93

23

10

21

13

10

55

68


D
O
W
N
L
O
A
D
S
060708091011120102
20252026

Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Author Tools
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.